Celyad Financial Statements From 2010 to 2024
| CYADDelisted Stock | USD 0.52 0.00 0.00% |
Check Celyad SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celyad SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Celyad financial statements analysis is a perfect complement when working with Celyad SA Valuation or Volatility modules.
Celyad |
Celyad SA Company Shares Outstanding Analysis
Celyad SA's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Celyad SA Shares Outstanding | 22.59 M |
Most of Celyad SA's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celyad SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Celyad SA has 22.59 M of shares currently outstending. This is 87.48% lower than that of the Biotechnology sector and 78.86% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 96.05% higher than that of the company.
Celyad SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Celyad SA's current stock value. Our valuation model uses many indicators to compare Celyad SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Celyad SA competition to find correlations between indicators driving Celyad SA's intrinsic value. More Info.Celyad SA is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Celyad SA by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Celyad SA Financial Statements
Celyad SA stakeholders use historical fundamental indicators, such as Celyad SA's revenue or net income, to determine how well the company is positioned to perform in the future. Although Celyad SA investors may analyze each financial statement separately, they are all interrelated. For example, changes in Celyad SA's assets and liabilities are reflected in the revenues and expenses on Celyad SA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Celyad SA. Please read more on our technical analysis and fundamental analysis pages.
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T cell therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. Celyad Sa operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Celyad Stock
If you are still planning to invest in Celyad SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celyad SA's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |